EMA Recommends Extending Indications for Decitabine / Cedazuridine By Ogkologos - May 29, 2026 161 0 Facebook Twitter Google+ Pinterest WhatsApp New indication concerns a combination with venetoclax for the treatment of adult patients with newly diagnosed AML Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin June 19, 2026 Cauliflower Rice August 28, 2020 Increasing Education About Cancer Screening and Prevention in Kazakhstan May 11, 2021 Young District Attorney Diagnosed with Breast Cancer Encourages Others to Get... November 30, 2020 Load more HOT NEWS Adding Relacorilant to Nab-paclitaxel Prolongs OS in Patients with Platinum-Resistant Ovarian... Plant-Based Diets and a New Treatment Combination for Prostate Cancer: Research... Five-Year Outcomes with CAR T Cell Therapy NALIRIFOX Improves Survival Compared with Nab-paclitaxel Plus Gemcitabine in First-Line Treatment...
